Who Paid My Doc
Ira Goldstein
Neurological Surgery Montclair, NJ Medical Doctor
NPI 1427088590 CMS profile 64797
70 Park St Ste 312, Montclair, NJ 07042
General payments
$343,706
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$27,512
Through program year 2025, Ira Goldstein of Montclair, NJ is reported in the CMS Open Payments database as having received $343,706 across 195 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $27,512 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 96th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $68,446 | 23 | |
| 2024 | General | $51,460 | 15 | |
| 2023 | General | $59,967 | 21 | |
| 2022 | General | $49,105 | 41 | |
| 2021 | General | $39,684 | 19 | |
| 2020 | General | $30,178 | 10 | |
| 2019 | General | $44,865 | 66 |
Beside peers
- Ira Goldstein
- Neurological Surgery median
- Middle half of Neurological Surgery
- National median
In program year 2025, general payments to Ira Goldstein were reported at $68,446. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.
Show as a table
| Year | Ira Goldstein | Neurological Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $44,865 | $582 | $138–$3,006 | $163 |
| 2020 | $30,178 | $294 | $76–$2,174 | $114 |
| 2021 | $39,684 | $387 | $105–$2,432 | $132 |
| 2022 | $49,105 | $542 | $139–$2,989 | $149 |
| 2023 | $59,967 | $534 | $145–$2,697 | $160 |
| 2024 | $51,460 | $574 | $155–$3,046 | $164 |
| 2025 | $68,446 | $596 | $159–$3,102 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 8 drugsPart D claims
182
Drug cost
$2,038
Branded share of claims
0%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Tizanidine Hcl | Generic | 48 | $956 | |
| Gabapentin | Generic | 44 | $503 | |
| Pregabalin | Generic | 14 | $151 | |
| Cyclobenzaprine Hcl | Generic | 13 | $140 | |
| Methocarbamol | Generic | 13 | $125 | |
| Meloxicam | Generic | 25 | $63 | |
| Diazepam | Generic | 12 | $59 | |
| Tramadol Hcl | Generic | 13 | $42 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.
Records
195 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neurological Surgery in New Jersey
Robert Heary
Neurological Surgery · Newark, NJ
Harshpal Singh
Neurological Surgery · Hackensack, NJ
Karthik Madhavan
Neurological Surgery · Cherry Hill, NJ
Simon Salerno
Neurological Surgery · Wall Township, NJ
Shabbar Danish
Neurological Surgery · Neptune, NJ
Adam Lipson
Neurological Surgery · Union, NJ
Related records
Neurological Surgery in New Jersey
Practitioners in the same specialty and state, ranked by reported value.
All Neurological Surgery
Everyone recorded under this specialty, nationwide.
Doctors in New Jersey
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.